Whole cohort, n= 585 | | | | |
Proportion in each phenotype, n (%) | 333 (56.9) | 189 (32.3) | 63 (10.8) | 18 (3.1) |
Daytime systolic BP, mmHg | 136.0 | 131.6 | 129.2 | 122.6 |
Night-time systolic BP, mmHg | 112.8 | 123.9 | 137.7 | 141.4 |
Day–night difference, mmHg | −23.2 | −7.7 | +8.5 | +18.8 |
24-hour mean systolic BP, mmHg | 128.6 | 129.8 | 133.3 | 130.5 |
Prevalence of cardiometabolic comorbidity, n (%) | 159 (47.7) | 110 (58.2) | 40 (63.5) | 12 (66.7) |
|
Males, n= 288 | | | | |
Proportion in each phenotype, n (%) | 163 (56.6) | 91 (31.6) | 34 (11.8) | 12 (4.2) |
Daytime systolic BP, mmHg | 138.1 | 131.3 | 129.3 | 121.7 |
Night-time systolic BP, mmHg | 114.0 | 123.4 | 137.6 | 138.5 |
Day–night difference, mmHg | −24.1 | −7.9 | +8.3 | +16.8 |
24-hour mean systolic BP, mmHg | 130.5 | 129.3 | 132.9 | 128.2 |
Prevalence of cardiometabolic comorbidity, n (%) | 89 (54.6) | 55 (60.4) | 22 (64.7) | 7 (58.3) |
|
Females, n= 297 | | | | |
Proportion in each phenotype, n (%) | 170 (57.2) | 98 (33.0) | 29 (9.8) | 6 (2.0) |
Daytime systolic BP, mmHg | 134.1 | 131.9 | 129.2 | 124.3 |
Night-time systolic BP, mmHg | 111.6 | 124.4 | 137.7 | 147.3 |
Day–night difference, mmHg | −22.5 | −7.5 | +8.5 | +23.0 |
24-hour mean systolic BP, mmHg | 126.8 | 130.2 | 133.9 | 135.1 |
Prevalence of cardiometabolic comorbidity, n (%) | 70 (41.2) | 55 (56.1) | 18 (62.1) | 5 (83.3) |